Mercer Global Advisors »

Cognition Therapeutics shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $242k 131k 1.85
2023-09-30 $23k 16k 1.44
2023-06-30 $29k 16k 1.82

More positions owned by Mercer Global Advisors

Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Apple (AAPL)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Vanguard Tax-managed Intl Ftse Dev M (VEA)
Vanguard Charlotte Fds Intl Bd Idx Etf (BNDX)
Microsoft Corporation (MSFT)
Ishares Tr Msci Usa Min Vol (USMV)
Dimensional Etf Trust Us High Profitab (DUHP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Shrt Nat Mun Etf (SUB)
Ishares Tr Msci Intl Moment (IMTM)

View all positions for Mercer Global Advisors

Top funds holding Cognition Therapeutics

Pathstone Holdings
AIGH Capital Management
Vanguard Group
Worth Venture Partners
Kestra Advisory Services
American Financial Group
Sigma Planning
Mercer Global Advisors
Commonwealth Equity Services
Texas Capital Bank Wealth Management Services
Fca Corp
Castle Wealth Management
HighTower Advisors
Northeast Financial Consultants
Bangor Savings Bank

View all funds holding Cognition Therapeutics